| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
04-11-2011, 08:23 AM
|
#1 | |||
|
||||
|
Senior Member
|
http://gooznews.com/?p=2692
...[The FDA] is considering opening the files on failed drug and device products to rival firms and independent researchers... "...Let’s not forget who else should be part of the conversation — the patients who agreed to participate in the clinical trials that determined the drug didn’t work or was unsafe... They agreed to take risks and, in double-blind placebo controlled trials, the 50 percent chance of forgoing treatment. This is why it is often difficult to recruit patients to participate in clinical trials. Both basic morality and scientific ethics dictate this data become public...
__________________
In the last analysis, we see only what we are ready to see, what we have been taught to see. We eliminate and ignore everything that is not a part of our prejudices. ~ Jean-Martin Charcot The future is already here — it's just not very evenly distributed. William Gibson |
|||
|
 Reply With Quote
|
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Need help deleting files! | Computers and Technology | |||
| Researchers offer insight into why so many ALS drugs failed in clinical trials | ALS News & Research | |||
| wav.m4a files???????? | Computers and Technology | |||
| Our Pet files | Bipolar Disorder | |||
FDA considers opening files on failed drugs and devices
Linear Mode
